Illumina’s $9.8M Security Snafu: The Cost of Ignoring DNA Data Safety
Biotech firm Illumina is shelling out $9.8 million to settle allegations of selling the government insecure DNA testing systems. Despite raking in hundreds of millions from contracts, the company claims they’ve fixed the software issues. Meanwhile, the Justice Department highlights the importance of cybersecurity in protecting sensitive genomic data.
Hot Take:
Oh, Illumina! Who knew the company that can crack your genetic code couldn’t crack the code to cybersecurity? But hey, a $9.8 million slap on the wrist is just pocket change when you’re rolling in DNA dough. Maybe they can use some of that cash to buy a cybersecurity handbook… or at least a really good lock for their digital doors!
Key Points:
- Illumina settles with the US government for $9.8 million over insecure genetic testing systems.
- Allegations claim Illumina sold vulnerable systems to the government for over seven years.
- No data breaches reported, but compliance with security standards was neglected.
- Despite the settlement, Illumina admits no guilt but plans to improve cybersecurity.
- Illumina controls over 80% of the global genetic testing market.
Already a member? Log in here